AP
aTyr Pharma, Inc.
🇺🇸XNAS.ATYRUnited StatesHealthcare
$0.38USDdown -0.01 (-2.56%)OpenDelayed5:11 PM
Price$0.38-0.01 (-2.56%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0021202025
- CUSIP
- 2120202
Company
- Employees
- 58
- Headquarters
- San Diego, United States
- Website
- https://atyrpharma.com
- CEO
- Dr. Sanjay S. Shukla M.D., M.S.
Market
- Shares outstanding
- 98.1M
- Market cap
- $37.27M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $38.25M
- EPS LTM
- -$0.62
- P/E LTM
- -0.61calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $190K+100%up year on year
- Net income
- -$60.81M+8.75%up year on year
- Gross margin
- -11,962.11%
- Free cash flow
- -$54.82M+1.5%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.